Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1950 2
1951 5
1953 1
1954 3
1956 1
1964 2
1973 1
1976 1
1977 1
1984 1
1985 2
1986 2
1987 2
1988 4
1991 6
1992 2
1993 3
1994 4
1995 5
1996 6
1997 9
1998 9
1999 8
2000 9
2001 12
2002 10
2003 10
2004 14
2005 15
2006 11
2007 21
2008 22
2009 26
2010 19
2011 30
2012 27
2013 14
2014 19
2015 17
2016 13
2017 8
2018 11
2019 10
2020 7
2021 13
2022 10
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

399 results
Results by year
Filters applied: . Clear all
Page 1
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: baker ga. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: baker ga. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group. Meador KJ, et al. Among authors: baker ga. Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23. Lancet Neurol. 2013. PMID: 23352199 Free PMC article. Clinical Trial.
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: baker ga. Lancet. 2007 Mar 24;369(9566):1016-26. doi: 10.1016/S0140-6736(07)60461-9. Lancet. 2007. PMID: 17382828 Free PMC article. Clinical Trial.
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: baker ga. Lancet. 2007 Mar 24;369(9566):1000-15. doi: 10.1016/S0140-6736(07)60460-7. Lancet. 2007. PMID: 17382827 Free PMC article. Clinical Trial.
WITHDRAWN: Psychological treatments for epilepsy.
Ramaratnam S, Baker GA, Goldstein LH. Ramaratnam S, et al. Among authors: baker ga. Cochrane Database Syst Rev. 2016 Feb 25;2:CD002029. doi: 10.1002/14651858.CD002029.pub4. Cochrane Database Syst Rev. 2016. PMID: 26912119 Review. No abstract available.
Psychological treatments for epilepsy.
Ramaratnam S, Baker GA, Goldstein LH. Ramaratnam S, et al. Among authors: baker ga. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002029. doi: 10.1002/14651858.CD002029.pub3. Cochrane Database Syst Rev. 2008. PMID: 18646083 Updated. Review.
Fluorescence, Phosphorescence, and Chemiluminescence.
Siraj N, El-Zahab B, Hamdan S, Karam TE, Haber LH, Li M, Fakayode SO, Das S, Valle B, Strongin RM, Patonay G, Sintim HO, Baker GA, Powe A, Lowry M, Karolin JO, Geddes CD, Warner IM. Siraj N, et al. Among authors: baker ga. Anal Chem. 2016 Jan 5;88(1):170-202. doi: 10.1021/acs.analchem.5b04109. Epub 2015 Dec 2. Anal Chem. 2016. PMID: 26575092 No abstract available.
399 results